Japan Claims There Is No Evidence That “Delinkage” Improves Medicines Access 16/07/2019 David Branigan Japan said on Friday that it disagrees with aspects of an already-adopted Human Rights Council (HRC) resolution on access to medicines, claiming that there is no evidence that “delinkage” between the cost of research & development (R&D) and the price of medicines improves access to medicines. Japan also disagreed with pursuing alternative frameworks for R&D […] Continue reading -> 20 million children miss out on lifesaving measles, diphtheria and tetanus vaccines in 2018 15/07/2019 Editorial team [WHO/UNICEF News Release] New York/Geneva – 20 million children worldwide – more than 1 in 10 – missed out on lifesaving vaccines such as measles, diphtheria and tetanus in 2018, according to new data from WHO and UNICEF. Globally, since 2010, vaccination coverage with three doses of diphtheria, tetanus and pertussis (DTP3) and one dose […] Continue reading -> Cancer Cases Growing Alarmingly, Can Alternative Therapies Support Response? 12/07/2019 Catherine Saez If the fight against cancer has yielded substantial results on survival rates in high-income countries, low- and middle-income countries are lagging behind, while cancer is gaining ground, with a particularly worrying trend in children. A first-ever International Health Congress on Integrative Oncology, held 28-30 June in Geneva, presented traditional and alternative medicines as precious allies […] Continue reading -> Resolutions To Combat Childhood Marriage and Increase Access to Medicines Approved by UN Human Rights Council 11/07/2019 Elaine Ruth Fletcher A UN Human Rights Council resolution calling for countries to combat childhood, early and forced marriages, and supported by over 60 UN member states, ran into heavy criticism today prior to its final approval. A number of countries in the Middle East, South-East Asia and North Africa publicly disassociated themselves from clauses promoting girls access […] Continue reading -> WHO’s New Essential Medicines List: CEO Of Patients’ Alliance Shares Views 10/07/2019 Guest contributor Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organizations (IAPO), answers 5 questions on why the Essential Medicines List is important for patients. IAPO is a United Kingdom-based alliance of 276 member organisations from 71 countries representing 50 disease areas, and working in collaboration with civil society, UN agencies and the healthcare industry. Sehmi holds a […] Continue reading -> New Cancer Drugs Top Entries On WHO Essential Medicines List 09/07/2019 Editorial team, Elaine Ruth Fletcher & David Branigan WHO has added ten new cancer drugs, including some pricey ones, to its 2019 Essential Medicines List, which provides global guidance to countries and health systems about drugs deemed most essential to patients and public health systems. The addition of major new cancer treatments in five categories, melanoma (skin), lung, blood and prostate cancers, reflects […] Continue reading -> “Delinkage” Of Medicines R&D From Patent Incentives Stirs Debate at Human Rights Council 04/07/2019 Elaine Ruth Fletcher Only a month after a hotly-contested World Health Assembly resolution touched off a debate around “price transparency” as a way to improve access to medicines, a new controversy over how to stimulate access has emerged in another UN Forum, the Human Rights Council. This time the debate is around ways to “delink” incentives for the […] Continue reading -> EU Calls For Results Of All EU-based Clinical Trials To Be Added To Public Database 04/07/2019 David Branigan The European Commission and European Union medicines regulatory agencies sent an open letter to all sponsors of EU-based clinical trials to remind them of their obligation to publish the results of the trials – both positive and negative – in a public database. The open letter by the European Commission (EC), the European Medicines Agency […] Continue reading -> GARDP To Develop & Deliver 5 New Treatments For Antibiotic Resistant Infections By 2025 04/07/2019 David Branigan The Global Antibiotic Research & Development Partnership (GARDP) has announced its new “5 BY 25” strategy to mobilise global stakeholders to raise the €500 million needed to develop and deliver five new antibiotic treatments by 2025, to help tackle antimicrobial resistance (AMR). Drug-resistant infections already cause at least 700,000 deaths globally each year, and affect […] Continue reading -> G20 Leaders Declare General Commitment To Advance Global Health 01/07/2019 David Branigan Heads of state from the world’s largest economies concluded this year’s G20 Summit in Japan with a general declaration committing to advance global health priorities – but the statement still left much to be desired in terms of concrete goals and targets. In the G20 Osaka Leaders’ Declaration, issued on Saturday at the close of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
20 million children miss out on lifesaving measles, diphtheria and tetanus vaccines in 2018 15/07/2019 Editorial team [WHO/UNICEF News Release] New York/Geneva – 20 million children worldwide – more than 1 in 10 – missed out on lifesaving vaccines such as measles, diphtheria and tetanus in 2018, according to new data from WHO and UNICEF. Globally, since 2010, vaccination coverage with three doses of diphtheria, tetanus and pertussis (DTP3) and one dose […] Continue reading -> Cancer Cases Growing Alarmingly, Can Alternative Therapies Support Response? 12/07/2019 Catherine Saez If the fight against cancer has yielded substantial results on survival rates in high-income countries, low- and middle-income countries are lagging behind, while cancer is gaining ground, with a particularly worrying trend in children. A first-ever International Health Congress on Integrative Oncology, held 28-30 June in Geneva, presented traditional and alternative medicines as precious allies […] Continue reading -> Resolutions To Combat Childhood Marriage and Increase Access to Medicines Approved by UN Human Rights Council 11/07/2019 Elaine Ruth Fletcher A UN Human Rights Council resolution calling for countries to combat childhood, early and forced marriages, and supported by over 60 UN member states, ran into heavy criticism today prior to its final approval. A number of countries in the Middle East, South-East Asia and North Africa publicly disassociated themselves from clauses promoting girls access […] Continue reading -> WHO’s New Essential Medicines List: CEO Of Patients’ Alliance Shares Views 10/07/2019 Guest contributor Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organizations (IAPO), answers 5 questions on why the Essential Medicines List is important for patients. IAPO is a United Kingdom-based alliance of 276 member organisations from 71 countries representing 50 disease areas, and working in collaboration with civil society, UN agencies and the healthcare industry. Sehmi holds a […] Continue reading -> New Cancer Drugs Top Entries On WHO Essential Medicines List 09/07/2019 Editorial team, Elaine Ruth Fletcher & David Branigan WHO has added ten new cancer drugs, including some pricey ones, to its 2019 Essential Medicines List, which provides global guidance to countries and health systems about drugs deemed most essential to patients and public health systems. The addition of major new cancer treatments in five categories, melanoma (skin), lung, blood and prostate cancers, reflects […] Continue reading -> “Delinkage” Of Medicines R&D From Patent Incentives Stirs Debate at Human Rights Council 04/07/2019 Elaine Ruth Fletcher Only a month after a hotly-contested World Health Assembly resolution touched off a debate around “price transparency” as a way to improve access to medicines, a new controversy over how to stimulate access has emerged in another UN Forum, the Human Rights Council. This time the debate is around ways to “delink” incentives for the […] Continue reading -> EU Calls For Results Of All EU-based Clinical Trials To Be Added To Public Database 04/07/2019 David Branigan The European Commission and European Union medicines regulatory agencies sent an open letter to all sponsors of EU-based clinical trials to remind them of their obligation to publish the results of the trials – both positive and negative – in a public database. The open letter by the European Commission (EC), the European Medicines Agency […] Continue reading -> GARDP To Develop & Deliver 5 New Treatments For Antibiotic Resistant Infections By 2025 04/07/2019 David Branigan The Global Antibiotic Research & Development Partnership (GARDP) has announced its new “5 BY 25” strategy to mobilise global stakeholders to raise the €500 million needed to develop and deliver five new antibiotic treatments by 2025, to help tackle antimicrobial resistance (AMR). Drug-resistant infections already cause at least 700,000 deaths globally each year, and affect […] Continue reading -> G20 Leaders Declare General Commitment To Advance Global Health 01/07/2019 David Branigan Heads of state from the world’s largest economies concluded this year’s G20 Summit in Japan with a general declaration committing to advance global health priorities – but the statement still left much to be desired in terms of concrete goals and targets. In the G20 Osaka Leaders’ Declaration, issued on Saturday at the close of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Cancer Cases Growing Alarmingly, Can Alternative Therapies Support Response? 12/07/2019 Catherine Saez If the fight against cancer has yielded substantial results on survival rates in high-income countries, low- and middle-income countries are lagging behind, while cancer is gaining ground, with a particularly worrying trend in children. A first-ever International Health Congress on Integrative Oncology, held 28-30 June in Geneva, presented traditional and alternative medicines as precious allies […] Continue reading -> Resolutions To Combat Childhood Marriage and Increase Access to Medicines Approved by UN Human Rights Council 11/07/2019 Elaine Ruth Fletcher A UN Human Rights Council resolution calling for countries to combat childhood, early and forced marriages, and supported by over 60 UN member states, ran into heavy criticism today prior to its final approval. A number of countries in the Middle East, South-East Asia and North Africa publicly disassociated themselves from clauses promoting girls access […] Continue reading -> WHO’s New Essential Medicines List: CEO Of Patients’ Alliance Shares Views 10/07/2019 Guest contributor Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organizations (IAPO), answers 5 questions on why the Essential Medicines List is important for patients. IAPO is a United Kingdom-based alliance of 276 member organisations from 71 countries representing 50 disease areas, and working in collaboration with civil society, UN agencies and the healthcare industry. Sehmi holds a […] Continue reading -> New Cancer Drugs Top Entries On WHO Essential Medicines List 09/07/2019 Editorial team, Elaine Ruth Fletcher & David Branigan WHO has added ten new cancer drugs, including some pricey ones, to its 2019 Essential Medicines List, which provides global guidance to countries and health systems about drugs deemed most essential to patients and public health systems. The addition of major new cancer treatments in five categories, melanoma (skin), lung, blood and prostate cancers, reflects […] Continue reading -> “Delinkage” Of Medicines R&D From Patent Incentives Stirs Debate at Human Rights Council 04/07/2019 Elaine Ruth Fletcher Only a month after a hotly-contested World Health Assembly resolution touched off a debate around “price transparency” as a way to improve access to medicines, a new controversy over how to stimulate access has emerged in another UN Forum, the Human Rights Council. This time the debate is around ways to “delink” incentives for the […] Continue reading -> EU Calls For Results Of All EU-based Clinical Trials To Be Added To Public Database 04/07/2019 David Branigan The European Commission and European Union medicines regulatory agencies sent an open letter to all sponsors of EU-based clinical trials to remind them of their obligation to publish the results of the trials – both positive and negative – in a public database. The open letter by the European Commission (EC), the European Medicines Agency […] Continue reading -> GARDP To Develop & Deliver 5 New Treatments For Antibiotic Resistant Infections By 2025 04/07/2019 David Branigan The Global Antibiotic Research & Development Partnership (GARDP) has announced its new “5 BY 25” strategy to mobilise global stakeholders to raise the €500 million needed to develop and deliver five new antibiotic treatments by 2025, to help tackle antimicrobial resistance (AMR). Drug-resistant infections already cause at least 700,000 deaths globally each year, and affect […] Continue reading -> G20 Leaders Declare General Commitment To Advance Global Health 01/07/2019 David Branigan Heads of state from the world’s largest economies concluded this year’s G20 Summit in Japan with a general declaration committing to advance global health priorities – but the statement still left much to be desired in terms of concrete goals and targets. In the G20 Osaka Leaders’ Declaration, issued on Saturday at the close of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Resolutions To Combat Childhood Marriage and Increase Access to Medicines Approved by UN Human Rights Council 11/07/2019 Elaine Ruth Fletcher A UN Human Rights Council resolution calling for countries to combat childhood, early and forced marriages, and supported by over 60 UN member states, ran into heavy criticism today prior to its final approval. A number of countries in the Middle East, South-East Asia and North Africa publicly disassociated themselves from clauses promoting girls access […] Continue reading -> WHO’s New Essential Medicines List: CEO Of Patients’ Alliance Shares Views 10/07/2019 Guest contributor Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organizations (IAPO), answers 5 questions on why the Essential Medicines List is important for patients. IAPO is a United Kingdom-based alliance of 276 member organisations from 71 countries representing 50 disease areas, and working in collaboration with civil society, UN agencies and the healthcare industry. Sehmi holds a […] Continue reading -> New Cancer Drugs Top Entries On WHO Essential Medicines List 09/07/2019 Editorial team, Elaine Ruth Fletcher & David Branigan WHO has added ten new cancer drugs, including some pricey ones, to its 2019 Essential Medicines List, which provides global guidance to countries and health systems about drugs deemed most essential to patients and public health systems. The addition of major new cancer treatments in five categories, melanoma (skin), lung, blood and prostate cancers, reflects […] Continue reading -> “Delinkage” Of Medicines R&D From Patent Incentives Stirs Debate at Human Rights Council 04/07/2019 Elaine Ruth Fletcher Only a month after a hotly-contested World Health Assembly resolution touched off a debate around “price transparency” as a way to improve access to medicines, a new controversy over how to stimulate access has emerged in another UN Forum, the Human Rights Council. This time the debate is around ways to “delink” incentives for the […] Continue reading -> EU Calls For Results Of All EU-based Clinical Trials To Be Added To Public Database 04/07/2019 David Branigan The European Commission and European Union medicines regulatory agencies sent an open letter to all sponsors of EU-based clinical trials to remind them of their obligation to publish the results of the trials – both positive and negative – in a public database. The open letter by the European Commission (EC), the European Medicines Agency […] Continue reading -> GARDP To Develop & Deliver 5 New Treatments For Antibiotic Resistant Infections By 2025 04/07/2019 David Branigan The Global Antibiotic Research & Development Partnership (GARDP) has announced its new “5 BY 25” strategy to mobilise global stakeholders to raise the €500 million needed to develop and deliver five new antibiotic treatments by 2025, to help tackle antimicrobial resistance (AMR). Drug-resistant infections already cause at least 700,000 deaths globally each year, and affect […] Continue reading -> G20 Leaders Declare General Commitment To Advance Global Health 01/07/2019 David Branigan Heads of state from the world’s largest economies concluded this year’s G20 Summit in Japan with a general declaration committing to advance global health priorities – but the statement still left much to be desired in terms of concrete goals and targets. In the G20 Osaka Leaders’ Declaration, issued on Saturday at the close of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO’s New Essential Medicines List: CEO Of Patients’ Alliance Shares Views 10/07/2019 Guest contributor Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organizations (IAPO), answers 5 questions on why the Essential Medicines List is important for patients. IAPO is a United Kingdom-based alliance of 276 member organisations from 71 countries representing 50 disease areas, and working in collaboration with civil society, UN agencies and the healthcare industry. Sehmi holds a […] Continue reading -> New Cancer Drugs Top Entries On WHO Essential Medicines List 09/07/2019 Editorial team, Elaine Ruth Fletcher & David Branigan WHO has added ten new cancer drugs, including some pricey ones, to its 2019 Essential Medicines List, which provides global guidance to countries and health systems about drugs deemed most essential to patients and public health systems. The addition of major new cancer treatments in five categories, melanoma (skin), lung, blood and prostate cancers, reflects […] Continue reading -> “Delinkage” Of Medicines R&D From Patent Incentives Stirs Debate at Human Rights Council 04/07/2019 Elaine Ruth Fletcher Only a month after a hotly-contested World Health Assembly resolution touched off a debate around “price transparency” as a way to improve access to medicines, a new controversy over how to stimulate access has emerged in another UN Forum, the Human Rights Council. This time the debate is around ways to “delink” incentives for the […] Continue reading -> EU Calls For Results Of All EU-based Clinical Trials To Be Added To Public Database 04/07/2019 David Branigan The European Commission and European Union medicines regulatory agencies sent an open letter to all sponsors of EU-based clinical trials to remind them of their obligation to publish the results of the trials – both positive and negative – in a public database. The open letter by the European Commission (EC), the European Medicines Agency […] Continue reading -> GARDP To Develop & Deliver 5 New Treatments For Antibiotic Resistant Infections By 2025 04/07/2019 David Branigan The Global Antibiotic Research & Development Partnership (GARDP) has announced its new “5 BY 25” strategy to mobilise global stakeholders to raise the €500 million needed to develop and deliver five new antibiotic treatments by 2025, to help tackle antimicrobial resistance (AMR). Drug-resistant infections already cause at least 700,000 deaths globally each year, and affect […] Continue reading -> G20 Leaders Declare General Commitment To Advance Global Health 01/07/2019 David Branigan Heads of state from the world’s largest economies concluded this year’s G20 Summit in Japan with a general declaration committing to advance global health priorities – but the statement still left much to be desired in terms of concrete goals and targets. In the G20 Osaka Leaders’ Declaration, issued on Saturday at the close of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New Cancer Drugs Top Entries On WHO Essential Medicines List 09/07/2019 Editorial team, Elaine Ruth Fletcher & David Branigan WHO has added ten new cancer drugs, including some pricey ones, to its 2019 Essential Medicines List, which provides global guidance to countries and health systems about drugs deemed most essential to patients and public health systems. The addition of major new cancer treatments in five categories, melanoma (skin), lung, blood and prostate cancers, reflects […] Continue reading -> “Delinkage” Of Medicines R&D From Patent Incentives Stirs Debate at Human Rights Council 04/07/2019 Elaine Ruth Fletcher Only a month after a hotly-contested World Health Assembly resolution touched off a debate around “price transparency” as a way to improve access to medicines, a new controversy over how to stimulate access has emerged in another UN Forum, the Human Rights Council. This time the debate is around ways to “delink” incentives for the […] Continue reading -> EU Calls For Results Of All EU-based Clinical Trials To Be Added To Public Database 04/07/2019 David Branigan The European Commission and European Union medicines regulatory agencies sent an open letter to all sponsors of EU-based clinical trials to remind them of their obligation to publish the results of the trials – both positive and negative – in a public database. The open letter by the European Commission (EC), the European Medicines Agency […] Continue reading -> GARDP To Develop & Deliver 5 New Treatments For Antibiotic Resistant Infections By 2025 04/07/2019 David Branigan The Global Antibiotic Research & Development Partnership (GARDP) has announced its new “5 BY 25” strategy to mobilise global stakeholders to raise the €500 million needed to develop and deliver five new antibiotic treatments by 2025, to help tackle antimicrobial resistance (AMR). Drug-resistant infections already cause at least 700,000 deaths globally each year, and affect […] Continue reading -> G20 Leaders Declare General Commitment To Advance Global Health 01/07/2019 David Branigan Heads of state from the world’s largest economies concluded this year’s G20 Summit in Japan with a general declaration committing to advance global health priorities – but the statement still left much to be desired in terms of concrete goals and targets. In the G20 Osaka Leaders’ Declaration, issued on Saturday at the close of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
“Delinkage” Of Medicines R&D From Patent Incentives Stirs Debate at Human Rights Council 04/07/2019 Elaine Ruth Fletcher Only a month after a hotly-contested World Health Assembly resolution touched off a debate around “price transparency” as a way to improve access to medicines, a new controversy over how to stimulate access has emerged in another UN Forum, the Human Rights Council. This time the debate is around ways to “delink” incentives for the […] Continue reading -> EU Calls For Results Of All EU-based Clinical Trials To Be Added To Public Database 04/07/2019 David Branigan The European Commission and European Union medicines regulatory agencies sent an open letter to all sponsors of EU-based clinical trials to remind them of their obligation to publish the results of the trials – both positive and negative – in a public database. The open letter by the European Commission (EC), the European Medicines Agency […] Continue reading -> GARDP To Develop & Deliver 5 New Treatments For Antibiotic Resistant Infections By 2025 04/07/2019 David Branigan The Global Antibiotic Research & Development Partnership (GARDP) has announced its new “5 BY 25” strategy to mobilise global stakeholders to raise the €500 million needed to develop and deliver five new antibiotic treatments by 2025, to help tackle antimicrobial resistance (AMR). Drug-resistant infections already cause at least 700,000 deaths globally each year, and affect […] Continue reading -> G20 Leaders Declare General Commitment To Advance Global Health 01/07/2019 David Branigan Heads of state from the world’s largest economies concluded this year’s G20 Summit in Japan with a general declaration committing to advance global health priorities – but the statement still left much to be desired in terms of concrete goals and targets. In the G20 Osaka Leaders’ Declaration, issued on Saturday at the close of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
EU Calls For Results Of All EU-based Clinical Trials To Be Added To Public Database 04/07/2019 David Branigan The European Commission and European Union medicines regulatory agencies sent an open letter to all sponsors of EU-based clinical trials to remind them of their obligation to publish the results of the trials – both positive and negative – in a public database. The open letter by the European Commission (EC), the European Medicines Agency […] Continue reading -> GARDP To Develop & Deliver 5 New Treatments For Antibiotic Resistant Infections By 2025 04/07/2019 David Branigan The Global Antibiotic Research & Development Partnership (GARDP) has announced its new “5 BY 25” strategy to mobilise global stakeholders to raise the €500 million needed to develop and deliver five new antibiotic treatments by 2025, to help tackle antimicrobial resistance (AMR). Drug-resistant infections already cause at least 700,000 deaths globally each year, and affect […] Continue reading -> G20 Leaders Declare General Commitment To Advance Global Health 01/07/2019 David Branigan Heads of state from the world’s largest economies concluded this year’s G20 Summit in Japan with a general declaration committing to advance global health priorities – but the statement still left much to be desired in terms of concrete goals and targets. In the G20 Osaka Leaders’ Declaration, issued on Saturday at the close of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
GARDP To Develop & Deliver 5 New Treatments For Antibiotic Resistant Infections By 2025 04/07/2019 David Branigan The Global Antibiotic Research & Development Partnership (GARDP) has announced its new “5 BY 25” strategy to mobilise global stakeholders to raise the €500 million needed to develop and deliver five new antibiotic treatments by 2025, to help tackle antimicrobial resistance (AMR). Drug-resistant infections already cause at least 700,000 deaths globally each year, and affect […] Continue reading -> G20 Leaders Declare General Commitment To Advance Global Health 01/07/2019 David Branigan Heads of state from the world’s largest economies concluded this year’s G20 Summit in Japan with a general declaration committing to advance global health priorities – but the statement still left much to be desired in terms of concrete goals and targets. In the G20 Osaka Leaders’ Declaration, issued on Saturday at the close of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
G20 Leaders Declare General Commitment To Advance Global Health 01/07/2019 David Branigan Heads of state from the world’s largest economies concluded this year’s G20 Summit in Japan with a general declaration committing to advance global health priorities – but the statement still left much to be desired in terms of concrete goals and targets. In the G20 Osaka Leaders’ Declaration, issued on Saturday at the close of […] Continue reading -> Posts navigation Older postsNewer posts